Negotiators Prioritize Generic And Biosimilar Oncology Drugs Over Newer Medicines

UICC And WHO Will Bargain For Cheaper Cancer Drugs For LMICs

 
• By Chloe Kent
Pills and syringes lying on top of a sheet of paper reading 'Cancer treatment'
Lack of screening and treatment in LMICs is leading to high cancer mortality • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation